Trial · NCT07880444
Effects of Daily Avocado Consumption on Sleep and Skin Health in Postmenopausal Females
NCT07880444, Not applicable, Not yet recruiting, San Diego State University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Daily Avocado Consumption on Sleep and Skin Health in Postmenopausal Females. Trials, record NCT07880444. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07880444
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Daily Avocado Consumption on Sleep and Skin Health in Postmenopausal Females
- NCT number
- NCT07880444
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 74 participants, estimated
- Lead sponsor
- San Diego State University
- Conditions
- Poor Sleep Quality
- Interventions
- Hass Avocado, Safflower Oil
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Actigraphy-Derived Sleep Efficiency | Baseline, Week 4, Week 8 | Sleep efficiency will be assessed using 7-day wrist actigraphy and expressed as the percentage of time in bed spent asleep. Change from baseline will be assessed at each follow-up. |
| Primary | Change in Slow-Wave Sleep Duration | Baseline, Week 4, Week 8 | Slow-wave (N3) sleep will be assessed using one night of at-home electroencephalography with the Zmachine Insight device and expressed as minutes and percentage of total sleep time. Change from baseline will be assessed at each follow-up. |
| Primary | Change in Actigraphy-Derived Sleep Fragmentation Index | Baseline, Week 4, Week 8 | Sleep fragmentation will be assessed using 7-day wrist actigraphy. Higher values indicate greater sleep fragmentation. Change from baseline will be assessed at each follow-up. |
| Primary | Change in Skin hydration | Baseline, Week 4, Week 8 | Skin hydration will be measured using corneometry at the forehead, periorbital region, dorsal hand, and upper inner arm. Values will be expressed in arbitrary units, with higher values indicating greater hydration. Change from baseline will be assessed at each follow-up. |
| Secondary | Change in Pittsburgh Sleep Quality Index (PSQI) Global Score | Baseline, Week 4, Week 8 | Subjective sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). Global scores range from 0 to 21, with higher scores indicating poorer sleep quality. Change from baseline will be assessed at each follow-up. |
| Secondary | Change in Insomnia Severity Index (ISI) Score | Baseline, Week 4, Week 8 | Insomnia severity will be assessed using the Insomnia Severity Index (ISI). Total scores range from 0 to 28, with higher scores indicating greater insomnia severity. Change from baseline will be assessed at each follow-up. |
| Secondary | Change in Epworth Sleepiness Scale (ESS) Score | Baseline, Week 4, Week 8 | Daytime sleepiness will be assessed using the Epworth Sleepiness Scale (ESS). Total scores range from 0 to 24, with higher scores indicating greater daytime sleepiness. Change from baseline will be assessed at each follow-up. |
| Secondary | Change in Ru-SATED Multidimensional Sleep Health Score | Baseline, Week 4, Week 8 | Multidimensional sleep health will be assessed using the RU-SATED Sleep Health Scale. Total scores range from 0 to 12, with higher scores indicating better sleep health. Change from baseline will be assessed at each follow-up. |
| Secondary | Change in Skin elasticity | Baseline, Week 4, Week 8 | Skin elasticity will be measured using an ElastiMeter® (Delfin Technologies Ltd., Kuopio, Finland). Instant Skin Elasticity (ISE) will be reported in newtons per meter (N/m), with higher values indicating greater skin elasticity. Change from baseline will be assessed at each follow-up. |
| Secondary | Change in Transepidermal water loss (TEWL) | Baseline, Week 4, Week 8 | Skin barrier function will be assessed by transepidermal water loss using a VapoMeter® and reported in g·m-²·h-¹. Change from baseline will be assessed at each follow-up. |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07880444
GET https://conductscience.org/api/trials/v1/NCT07880444/registered?page=2